Bill Batchelor highlights the far-reaching implications of the AstraZeneca judgment.
On 1 July 2010, the European Union General Court handed down its judgment in the long-running saga of AstraZeneca's proton pump inhibitor anti-ulcer product, Losec (omeprazole)1,2...
Please login to read the full article.
